Divesting for value: world class divesting
Hosted by Ernst & Young Transaction Advisory Services
June 20, 2012 4:00 GMT
June 20, 2012 5:00 GMT
Private equity (PE) portfolio companies and private enterprises eventually reach a point where they determine how best to monetize their investment to provide shareholder returns.
Many decide between selling the enterprise, preparing for an IPO or other capital-raising alternatives while running concurrent processes to determine the best strategy.
According to our recent US Capital Confidence Barometer, 34% of respondents are planning to divest or pursue an acquisition in the next 12 months. In addition, there is an expected increase in PE exits. Both are indicators that the potential for large deal volume is very real.
Whether you are a PE looking to exit or a private company contemplating an enterprise sale, a greater emphasis on preparation will be required to succeed and maximize transaction value in today's environment.
Join a panel of leading private equity and corporate executives as they share their insights and experiences in world class divesting.
Watch the one-minute recap from this webcast:
"Excellent discussion on the alternatives to divesting. Good discussion on the process and pitfalls to avoid to maximize value."- XBRL Financial Reporting Specialist, Professional Firms & Services
Partner, Ernst & Young LLP (UK), Global Banking & Capital Markets
Philippe Leroy is the transaction support divestiture leader for the New York area. With more than 15 years of public accounting experience, Philippe has been providing buy and sell-side M&A financial due diligence advice to both private equity and strategic buyer clients in broad range of industries such as media and entertainment, technology, and commercial businesses.
Vice President and Worldwide General Manager of Hewlett-Packard to Vice President and Worldwide General Manager, Hewlett-Packard
Rob Scott is Vice President and Worldwide General Manager of Hewlett-Packard. He joined Hewlett Packard in 2008 following its acquisition of Colubris Networks where he, as Colubris' Chief Executive Officer, had navigated the transaction. Over his recent career he has led five startups, two restarts and one internally-incubated venture to successful outcomes.
Managing Director of CCMP Capital to Managing Director, CCMP Capital Advisors
Kevin O'Brien is a Managing Director of CCMP Capital and a member of the firm's Investment Committee. Mr. O'Brien focuses on making investments in the healthcare, consumer, retail and media sectors and has been responsible for CCMP's investments in CareMore Medical Enterprises, Kraton Polymers, Infogroup, La Petite Academy, LHP Hospital Group, Medpace, National Surgical Care, National Waterworks and Pinnacle Foods Group. In addition, Mr. O'Brien oversees the execution of debt capital markets transactions undertaken by the firm.
Ernst & Young LLP, (US) Divestiture Advisory Services to Ernst & Young LLP (US), Divestiture Advisory Services
Richard Mills is the divestiture advisory services leader for EY's Southeast Area TAS practice. He has been dedicated to providing transaction advisory services for more than ten years and has over 15 years of public accounting experience. Rich's divestiture-specific experience includes: providing carve-out financial statement preparation assistance and divestiture due diligence support on a $4.1B sale of a global consumer products segment with operations in over 45 countries; providing divestiture due diligence support for a multi-billion dollar sale of a global industrial products manufacturer; providing divestiture due diligence support related to the carve-out of a US-based financial services company; advising on carve-out accounting matters related to the spin off of a segment of a services company; advising on the carve-out of selected products in Brazil for contribution in a joint venture transaction; and providing divestiture due diligence support for the $850M sale of a multi-entity industrial products company in Mexico.
"Good discussion. Liked the focus on the business perspective and practical information."- Assistant Controller, Biotechnology